ARG1 and neoplasm: Concurrently, they establish an immunosuppressive microenvironment through arginase-1-mediated arginine depletion, which impairs T-cell function (270), and recruit tumor-promoting macrophages and Tregs, fostering tumor growth and sorafenib resistance (276).